ApprovalTrail

Approval · Notice of Compliance 34871 · 2025

TRIDURAL: Notice of Compliance 34871

Issued February 19, 2025

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
34871
Date
February 19, 2025
Company
Endo Operations Ltd.Ballsbridge, Dublin, Ireland
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Labelling Only

Products in this notice

BrandDINStatus today
TRIDURAL02296381Marketed
TRIDURAL02296403Marketed
TRIDURAL02296411Marketed

Medicinal ingredients